Conversely, in preclinical studies, the presence of immunosuppressive CD4+CD25+FOXP3+ regulatory T cells and immunosuppressive soluble factors inside the tumor corresponded with poor prognosis in MPM, due to suppression of anti-tumor immune responses [76]. The gene discussed is CD4; the disease is neoplasm.